Drug recall · June 12, 2013
Baclofen/Bupivacaine 2 recall
Why: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Baclofen/Bupivacaine 2,000 mcg/20 mg/mL Injectable, 45 mL vial, Compounded by The Compounding Shop, St. Petersburg, FL
- Lots / codes
All Lots
- Quantity
- 3 vials of 45mL
- Company
- The Compounding Shop, Inc., St Petersburg, FL
- Distribution
- Florida, California, Minnesota, and Maine
- Initiated
- May 2, 2013 · Voluntary: Firm initiated
- Classified
- June 4, 2013
- Reported
- June 12, 2013
- Ended
- September 30, 2024
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Baclofen
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.